Literature DB >> 8200892

Total hip arthroplasty without cement in obese patients. A minimum two-year clinical and radiographic follow-up study.

D E Lehman1, W N Capello, J R Feinberg.   

Abstract

A retrospective study of patients who had had a primary total hip arthroplasty without cement between 1983 and 1990 was done to examine differences in clinical and radiographic results between obese and normal-weight individuals. Patients were considered to be of normal weight if the body-mass index (calculated as weight in kilograms divided by height in meters squared) was between twenty and less than thirty, and they were considered to be obese if the body-mass index was thirty or more. There were 127 normal-weight patients (142 hips) and fifty-five obese patients (sixty hips) in the analysis. Eight obese patients (eight hips) who had a body-mass index of forty or more were considered to be morbidly obese and were examined separately as a subset of the obese group. The duration of follow-up averaged forty-eight months (range, twenty-four to ninety-two months). There were no differences between the groups with regard to age, diagnosis, the type of stem or cup, the type of bone, the postoperative level of activity, or the duration of follow-up. The obese patients had a significantly greater loss of blood during the operation than the patients in the normal-weight group. There were no significant differences between groups with regard to the prevalence of perioperative complications, the number of units of blood transfused, the operative duration, or the duration of hospitalization. Of the 202 hips, 184 (91 percent) were pain-free or only mildly painful at the latest follow-up examination.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8200892     DOI: 10.2106/00004623-199406000-00009

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  15 in total

1.  Meta-analysis shows that obesity may be a significant risk factor for prosthetic joint infections.

Authors:  Zhongxi Ma; Fengjin Guo; Jun Qi; Wei Xiang; Jinming Zhang
Journal:  Int Orthop       Date:  2015-08-15       Impact factor: 3.075

2.  Obesity is associated with higher complication rates in revision total hip arthroplasty.

Authors:  John W Kennedy; David Young; Dominic R M Meek; Sanjeev R Patil
Journal:  J Orthop       Date:  2018-01-30

3.  Total hip replacement: indications for surgery and risk factors for failure.

Authors:  R W Crawford; D W Murray
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

4.  No influence of body mass index on early outcome following total hip arthroplasty.

Authors:  T Ibrahim; S Hobson; A Beiri; C N Esler
Journal:  Int Orthop       Date:  2005-09-24       Impact factor: 3.075

5.  Do obese patients bleed more? A prospective study of blood loss at total hip replacement.

Authors:  M G Bowditch; R N Villar
Journal:  Ann R Coll Surg Engl       Date:  1999-05       Impact factor: 1.891

6.  Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

7.  Outcome of an ultrashort metaphyseal-fitting anatomic cementless stem in highly active obese and non-obese patients.

Authors:  Young-Hoo Kim; Jang-Won Park; Jun-Shik Kim
Journal:  Int Orthop       Date:  2014-09-16       Impact factor: 3.075

8.  Custom made Ilizarov ring fixator for fracture care in morbidly obese patients.

Authors:  Dominik Seybold; Jan Gessmann; Levent Ozokyay; Thomas Frangen; Gert Muhr; Markus Graf
Journal:  Langenbecks Arch Surg       Date:  2008-05-31       Impact factor: 3.445

9.  Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty.

Authors:  Michelle M Dowsey; Peter F M Choong
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

10.  Two-year outcomes in primary THA in obese male veterans administration medical center patients.

Authors:  James A Grant; Nicholas Viens; Michael P Bolognesi; Steven A Olson; Chad E Cook
Journal:  Rheumatol Int       Date:  2008-04-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.